Phase 3 Start

SMNR: Phase3_Start: Corticosteroid Lumbar Epidural Analgesia for Radicular Pain (C.L.E.A.R) 2 - A Randomized, Double-blind, Active Comparator and Placebo-controlled, Multicenter, Safety and Efficacy Trial of SP-102

Name: Phase3_Start: Corticosteroid Lumbar Epidural Analgesia for Radicular Pain (C.L.E.A.R) 2 - A Randomized, Double-blind, Active Comparator and Placebo-controlled, Multicenter, Safety and Efficacy Trial of SP-102
Start: 2027-02-01
End: 2027-02-01

February 1, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: February 1, 2027
Company: SEMNUR PHARMACEUTICALS, INC. (SMNR)

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Phase 3 Start

Phase3_Start: Corticosteroid Lumbar Epidural Analgesia for Radicular Pain (C.L.E.A.R) 2 - A Randomized, Double-blind, Active Comparator and Placebo-controlled, Multicenter, Safety and Efficacy Trial of SP-102

February 1, 2027

SMNR overview →

Company: SEMNUR PHARMACEUTICALS, INC. (SMNR)